title: Papillomavirus E2 induces p53-independent apoptosis in HeLa cells.
abstract: We have previously shown that expression of the papillomavirus E2 protein in HeLa cells induces p53 accumulation and causes both cell cycle arrest and apoptosis. In contrast to growth arrest, onset of apoptosis was not correlated with an increase of p53 transcriptional activity. In the present study, we conducted biochemical and genetic experiments in order to determine whether E2-induced apoptosis was independent of p53 induction. We showed that E2 did not alter the transcription of Bax, a known p53-activated cell death inducer. The time course of apoptotic cell death preceded p53 induction by several hours. Overexpression of the HPV18 E6 oncogene prevented E2-mediated p53 accumulation, but did not alter the rate of cell death. Finally, point mutants of the HPV18 E2 transactivation domain induced apoptosis, although they were unable to induce high p53 accumulation or cell cycle arrest. In addition, the results obtained with these mutants indicated that both transcriptional activation and replication functions of E2 were dispensable for the induction of cell death. These observations show that E2-induced apoptosis is an early event, independent of p53 accumulation and unrelated to downstream p53-dependent transcriptional events.
authors.affiliation: Unité des virus oncogènes, département des biotechnologies, URA 1644 du CNRS, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris, cedex 15, Paris, France.
authors.forename: C
authors.initials: C
authors.lastname: Desaintes
authors.forename: S
authors.initials: S
authors.lastname: Goyat
authors.forename: S
authors.initials: S
authors.lastname: Garbay
authors.forename: M
authors.initials: M
authors.lastname: Yaniv
authors.forename: F
authors.initials: F
authors.lastname: Thierry
mesh_terms: D000818:Animals; D017209:Apoptosis; D001665:Binding Sites; D052688:Bovine papillomavirus 1; D002417:Cattle; D002461:Cell Line, Transformed; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D016297:Mutagenesis, Site-Directed; D009856:Oncogene Proteins, Viral / Q000235:genetics / Q000378:metabolism*; D027383:Papillomaviridae; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis / Q000235:genetics; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000096:biosynthesis / Q000235:genetics; D013997:Time Factors; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism*; D015533:Transcriptional Activation; D016159:Tumor Suppressor Protein p53 / Q000235:genetics / Q000378:metabolism*; D014764:Viral Proteins / Q000235:genetics / Q000378:metabolism*; D051028:bcl-2-Associated X Protein
chemical_list: C494826:BAX protein, human; D004268:DNA-Binding Proteins; C051550:E2 protein, Bovine papillomavirus; C052603:E6 protein, Human papillomavirus type 18; D009856:Oncogene Proteins, Viral; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D015534:Trans-Activators; D016159:Tumor Suppressor Protein p53; D014764:Viral Proteins; D051028:bcl-2-Associated X Protein; C069102:oncogene protein E2, Human papillomavirus type 18